title: Microbial cytochromes P450: biodiversity and biotechnology. Where do cytochromes P450 come from, what do they do and what can they do for us?
abstract: The first eukaryote genome revealed three yeast cytochromes P450 (CYPs), hence the subsequent realization that some microbial fungal genomes encode these proteins in 1 per cent or more of all genes (greater than 100) has been surprising. They are unique biocatalysts undertaking a wide array of stereo- and regio-specific reactions and so hold promise in many applications. Based on ancestral activities that included 14α-demethylation during sterol biosynthesis, it is now seen that CYPs are part of the genes and metabolism of most eukaryotes. In contrast, Archaea and Eubacteria often do not contain CYPs, while those that do are frequently interesting as producers of natural products undertaking their oxidative tailoring. Apart from roles in primary and secondary metabolism, microbial CYPs are actual/potential targets of drugs/agrochemicals and CYP51 in sterol biosynthesis is exhibiting evolution to resistance in the clinic and the field. Other CYP applications include the first industrial biotransformation for corticosteroid production in the 1950s, the diversion into penicillin synthesis in early mutations in fungal strain improvement and bioremediation using bacteria and fungi. The vast untapped resource of orphan CYPs in numerous genomes is being probed and new methods for discovering function and for discovering desired activities are being investigated.
authors.affiliation: Centre for Cytochrome P450 Biodiversity, Institute of Life Science and College of Medicine, Swansea University, Singleton Park, Swansea SA2 8PP, UK. s.l.kelly@swansea.ac.uk
authors.forename: Steven L
authors.initials: SL
authors.lastname: Kelly
authors.forename: Diane E
authors.initials: DE
authors.lastname: Kelly
mesh_terms: D000935:Antifungal Agents / Q000494:pharmacology; D001419:Bacteria / Q000201:enzymology* / Q000235:genetics / Q000378:metabolism; D001688:Biological Products / Q000378:metabolism; D001709:Biotechnology / Q000379:methods; D003577:Cytochrome P-450 Enzyme System / Q000235:genetics / Q000378:metabolism*; D025141:Drug Resistance, Fungal; D004583:Electrons; D019143:Evolution, Molecular; D005658:Fungi / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism; D006801:Humans; D009154:Mutation; D009181:Mycoses / Q000188:drug therapy / Q000201:enzymology / Q000382:microbiology; D010100:Oxygen / Q000378:metabolism; D013261:Sterols / Q000096:biosynthesis*
chemical_list: D000935:Antifungal Agents; D001688:Biological Products; D013261:Sterols; D003577:Cytochrome P-450 Enzyme System; D010100:Oxygen